118 related articles for article (PubMed ID: 28560748)
21. MTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patients.
Su CY; Chang YC; Chan YC; Lin TC; Huang MS; Yang CJ; Hsiao M
Eur J Surg Oncol; 2014 Sep; 40(9):1143-50. PubMed ID: 24969958
[TBL] [Abstract][Full Text] [Related]
22. Osteosarcoma of the jaws: factors influencing prognosis.
Granowski-LeCornu M; Chuang SK; Kaban LB; August M
J Oral Maxillofac Surg; 2011 Sep; 69(9):2368-75. PubMed ID: 21288615
[TBL] [Abstract][Full Text] [Related]
23. [Clinical features and treatment of osteogenic sarcoma of the jaws].
Herrmann A; Zöller J
Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(3):180-6. PubMed ID: 2102427
[TBL] [Abstract][Full Text] [Related]
24. P16 positivity and regression grade predict survival after neoadjuvant radiotherapy of OSCC.
Eder-Czembirek C; Sulzbacher I; Fuereder T; Selzer E
Oral Dis; 2018 May; 24(4):544-551. PubMed ID: 29215771
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of p16 in squamous cell carcinoma of the larynx and hypopharynx.
Meshman J; Wang PC; Chin R; John MS; Abemayor E; Bhuta S; Chen AM
Am J Otolaryngol; 2017; 38(1):31-37. PubMed ID: 27751621
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1, p16(INK) (4A) and p27(Kip1) in pancreatic adenocarcinoma: assessing prognostic implications through quantitative image analysis.
Georgiadou D; Sergentanis TN; Sakellariou S; Filippakis GM; Zagouri F; Vlachodimitropoulos D; Psaltopoulou T; Lazaris AC; Patsouris E; Zografos GC
APMIS; 2014 Dec; 122(12):1230-9. PubMed ID: 25053516
[TBL] [Abstract][Full Text] [Related]
27. P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis.
Bu J; Li H; Liu LH; Ouyang YR; Guo HB; Li XY; Xiao T
Int J Clin Exp Pathol; 2014; 7(9):6091-6. PubMed ID: 25337256
[TBL] [Abstract][Full Text] [Related]
28. The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.
Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):253-259. PubMed ID: 27918781
[TBL] [Abstract][Full Text] [Related]
29. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
[TBL] [Abstract][Full Text] [Related]
30. Reporting Surgical Resection Margin Status for Osteosarcoma: Comparison of the AJCC, MSTS, and Margin Distance Methods.
Cates JM
Am J Surg Pathol; 2017 May; 41(5):633-642. PubMed ID: 28125453
[TBL] [Abstract][Full Text] [Related]
31. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
[TBL] [Abstract][Full Text] [Related]
32. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.
Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK
Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865
[TBL] [Abstract][Full Text] [Related]
33. Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients.
Nataraj V; Rastogi S; Khan SA; Sharma MC; Agarwala S; Vishnubhatla S; Bakhshi S
Clin Transl Oncol; 2016 Sep; 18(9):937-44. PubMed ID: 26742936
[TBL] [Abstract][Full Text] [Related]
34. Lack of efficacy of neoadjuvant chemotherapy in adult patients with maxillo-facial high-grade osteosarcomas: A French experience in two reference centers.
Bouaoud J; Beinse G; Epaillard N; Amor-Sehlil M; Bidault F; Brocheriou I; Hervé G; Spano JP; Janot F; Boudou-Rouquette P; Benassarou M; Schouman T; Goudot P; Malouf G; Goldwasser F; Bertolus C
Oral Oncol; 2019 Aug; 95():79-86. PubMed ID: 31345398
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.
Lee CT; Capodieci P; Osman I; Fazzari M; Ferrara J; Scher HI; Cordon-Cardo C
Clin Cancer Res; 1999 May; 5(5):977-83. PubMed ID: 10353729
[TBL] [Abstract][Full Text] [Related]
36. Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience.
Berlanga P; Cañete A; Salom M; Montalar J; Guasp M; Marco A; Castel V
J Pediatr Hematol Oncol; 2016 Apr; 38(3):176-81. PubMed ID: 26925713
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of senescence markers p14(ARF) and p16(INK4a) in breast cancer is associated with an increased risk of disease recurrence and poor survival outcome.
Pare R; Shin JS; Lee CS
Histopathology; 2016 Sep; 69(3):479-91. PubMed ID: 26843058
[TBL] [Abstract][Full Text] [Related]
38. Expression of CD44, EGFR, p16, and their mutual combinations in patients with head and neck cancer: Impact on outcomes of intensity-modulated radiation therapy.
Slavik M; Shatokhina T; Sana J; Ahmad P; Kazda T; Selingerova I; Hermanova M; Cervena R; Novotny T; Burkon P; Smilek P; Horakova Z; Slampa P; Slaby O
Head Neck; 2019 Apr; 41(4):940-949. PubMed ID: 30552846
[TBL] [Abstract][Full Text] [Related]
39. Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy.
Hattinger CM; Michelacci F; Sella F; Magagnoli G; Benini S; Gambarotti M; Palmerini E; Picci P; Serra M; Ferrari S
Histopathology; 2015 Sep; 67(3):338-47. PubMed ID: 25600168
[TBL] [Abstract][Full Text] [Related]
40. Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma.
Huber GF; Albinger-Hegyi A; Soltermann A; Roessle M; Graf N; Haerle SK; Holzmann D; Moch H; Hegyi I
Cancer; 2011 Oct; 117(20):4659-70. PubMed ID: 21448927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
